Literature DB >> 17517839

Increased expression of ampC in Pseudomonas aeruginosa mutants selected with ciprofloxacin.

Daniel J Wolter1, Amber J Schmidtke, Nancy D Hanson, Philip D Lister.   

Abstract

Two Pseudomonas aeruginosa mutants exhibiting increased expression of ampC were selected during exposure to ciprofloxacin. These mutants also exhibited significant increases in mexCD-oprJ expression, but further studies failed to show a link between the increased expression of mexCD-oprJ and ampC. Increased ampC expression was not related to mutations within ampR, the ampC-ampR intergenic region, ampD, ampDh2, or ampDh3 or to changes in the levels of expression of these amidase genes. However, ampD complementation restored wild-type levels of ampC expression and ceftazidime susceptibility, suggesting alternative mechanisms of ampC regulation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17517839      PMCID: PMC1932541          DOI: 10.1128/AAC.00111-07

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  24 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

2.  Defining the Pseudomonas aeruginosa SOS response and its role in the global response to the antibiotic ciprofloxacin.

Authors:  Ryan T Cirz; Bryan M O'Neill; Jennifer A Hammond; Steven R Head; Floyd E Romesberg
Journal:  J Bacteriol       Date:  2006-10       Impact factor: 3.490

3.  Inactivation of the ampD gene in Pseudomonas aeruginosa leads to moderate-basal-level and hyperinducible AmpC beta-lactamase expression.

Authors:  T Y Langaee; L Gagnon; A Huletsky
Journal:  Antimicrob Agents Chemother       Date:  2000-03       Impact factor: 5.191

4.  Transformation of Pseudomonas aeruginosa by electroporation.

Authors:  A W Smith; B H Iglewski
Journal:  Nucleic Acids Res       Date:  1989-12-25       Impact factor: 16.971

5.  Type I beta-lactamases of gram-negative bacteria: interactions with beta-lactam antibiotics.

Authors:  C C Sanders; W E Sanders
Journal:  J Infect Dis       Date:  1986-11       Impact factor: 5.226

6.  Induction of the SOS response by new 4-quinolones.

Authors:  I Phillips; E Culebras; F Moreno; F Baquero
Journal:  J Antimicrob Chemother       Date:  1987-11       Impact factor: 5.790

7.  Constitutive high expression of chromosomal beta-lactamase in Pseudomonas aeruginosa caused by a new insertion sequence (IS1669) located in ampD.

Authors:  Niels Bagge; Oana Ciofu; Morten Hentzer; Joan I A Campbell; Michael Givskov; Niels Høiby
Journal:  Antimicrob Agents Chemother       Date:  2002-11       Impact factor: 5.191

8.  Beta-lactamase lability and inducer power of newer beta-lactam antibiotics in relation to their activity against beta-lactamase-inducibility mutants of Pseudomonas aeruginosa.

Authors:  D M Livermore; Y J Yang
Journal:  J Infect Dis       Date:  1987-04       Impact factor: 5.226

9.  Multidrug resistance associated with mexXY expression in clinical isolates of Pseudomonas aeruginosa from a Texas hospital.

Authors:  Daniel J Wolter; Ellen Smith-Moland; Richard V Goering; Nancy D Hanson; Philip D Lister
Journal:  Diagn Microbiol Infect Dis       Date:  2004-09       Impact factor: 2.803

10.  Analyses of ampC gene expression in Serratia marcescens reveal new regulatory properties.

Authors:  Steven D Mahlen; Stacey S Morrow; Baha Abdalhamid; Nancy D Hanson
Journal:  J Antimicrob Chemother       Date:  2003-02-25       Impact factor: 5.790

View more
  6 in total

1.  Evolution of Pseudomonas aeruginosa Antimicrobial Resistance and Fitness under Low and High Mutation Rates.

Authors:  Gabriel Cabot; Laura Zamorano; Bartolomé Moyà; Carlos Juan; Alfonso Navas; Jesús Blázquez; Antonio Oliver
Journal:  Antimicrob Agents Chemother       Date:  2016-01-04       Impact factor: 5.191

Review 2.  Antibacterial-resistant Pseudomonas aeruginosa: clinical impact and complex regulation of chromosomally encoded resistance mechanisms.

Authors:  Philip D Lister; Daniel J Wolter; Nancy D Hanson
Journal:  Clin Microbiol Rev       Date:  2009-10       Impact factor: 26.132

3.  Role of ampD homologs in overproduction of AmpC in clinical isolates of Pseudomonas aeruginosa.

Authors:  Amber J Schmidtke; Nancy D Hanson
Journal:  Antimicrob Agents Chemother       Date:  2008-09-08       Impact factor: 5.191

Review 4.  Responses of Pseudomonas aeruginosa to antimicrobials.

Authors:  Yuji Morita; Junko Tomida; Yoshiaki Kawamura
Journal:  Front Microbiol       Date:  2014-01-08       Impact factor: 5.640

5.  Benefits and unintended consequences of antimicrobial de-escalation: Implications for stewardship programs.

Authors:  Josie Hughes; Xi Huo; Lindsey Falk; Amy Hurford; Kunquan Lan; Bryan Coburn; Andrew Morris; Jianhong Wu
Journal:  PLoS One       Date:  2017-02-09       Impact factor: 3.240

6.  Determination of carbapenem resistance mechanism in clinical isolates of Pseudomonas aeruginosa isolated from burn patients, in Tehran, Iran.

Authors:  Akbar Mirsalehian; Davood Kalantar-Neyestanaki; Morovat Taherikalani; Fereshteh Jabalameli; Mohammad Emaneini
Journal:  J Epidemiol Glob Health       Date:  2017-04-29
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.